{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:30:33Z","timestamp":1773729033203,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The anti\u2010Hu syndrome is a well\u2010known paraneoplastic syndrome and may be rarely seen in patients with neuroblastoma. However, it is relatively unknown that anti\u2010Hu antibodies can cause gastro\u2010intestinal signs and symptoms. We report on a child with neuroblastoma who presented with gastro\u2010intestinal disturbances as a result of the anti\u2010Hu syndrome and summaries two similar case reports reported in literature. Neuroblastoma patients with gastro\u2010intestinal disturbances, ranging from constipation to a paralytic ileus, might suffer from the gastro\u2010intestinal anti\u2010Hu syndrome. The causative antibodies can be determined to diagnose or exclude this syndrome, and successful treatment is possible. Pediatr Blood Cancer 2009;52:396\u2013398. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.21807","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T16:18:28Z","timestamp":1225988308000},"page":"396-398","source":"Crossref","is-referenced-by-count":21,"title":["Paraneoplastic gastro\u2010intestinal anti\u2010Hu syndrome in neuroblastoma"],"prefix":"10.1002","volume":"52","author":[{"given":"C.A.M.","family":"Drukker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.","family":"Heij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.D.","family":"Wijnaendts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.I.M.L.","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200007000-00007"},{"key":"e_1_2_6_3_2","first-page":"799","article-title":"A boy with acute cerebellar ataxia without opsoclonus caused by neuroblastoma","volume":"150","author":"Blokker RS","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2006.04.019"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(94)90127-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R"},{"key":"e_1_2_6_7_2","first-page":"94","article-title":"Paraneoplastic syndromes associated with anti\u2010Hu antibodies","volume":"3","author":"Senties\u2010Madrid H","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199905000-00016"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1212-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00664-4"},{"key":"e_1_2_6_11_2","first-page":"2819","article-title":"DNA vaccination with HuD inhibits growth of a neuroblastoma in mice","volume":"4","author":"Carpentier AF","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00029-5"},{"key":"e_1_2_6_13_2","first-page":"2943","article-title":"IFN\u2010treated neuroblastoma cell\u2010lines remain resistant to T\u2010cell mediated allo\u2010killing, and susceptible to non\u2010MHC cytotoxity","volume":"141","author":"Main EK","year":"1988","journal-title":"Am Assoc Immnol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01606543"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf006"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0706-4"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2004-8"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21807","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:03:10Z","timestamp":1695949390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,8]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1002\/pbc.21807"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21807","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,8]]}}}